BDBM50044927 CHEMBL3309313

SMILES: CN(C)CCOc1ccc(c(CN2CCN(CC2)c2ccc(cc2)C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN3CCOCC3)CSc3ccccc3)c(c2)S(=O)(=O)C(F)(F)F)c1)-c1ccc(Cl)cc1

InChI Key: InChIKey=RIYGZTVWQQZXPA-RRHRGVEJSA-N

Data: 4 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 50044927   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Apoptosis regulator Bcl-2 (Homo sapiens (Human))	BDBM50044927 (CHEMBL3309313) Show SMILES CN(C)CCOc1ccc(c(CN2CCN(CC2)c2ccc(cc2)C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN3CCOCC3)CSc3ccccc3)c(c2)S(=O)(=O)C(F)(F)F)c1)-c1ccc(Cl)cc1 |r| Show InChI InChI=1S/C49H56ClF3N6O7S3/c1-56(2)26-31-66-42-16-18-45(36-8-12-39(50)13-9-36)38(32-42)34-58-22-24-59(25-23-58)41-14-10-37(11-15-41)48(60)55-69(63,64)44-17-19-46(47(33-44)68(61,62)49(51,52)53)54-40(20-21-57-27-29-65-30-28-57)35-67-43-6-4-3-5-7-43/h3-19,32-33,40,54H,20-31,34-35H2,1-2H3,(H,55,60)/t40-/m1/s1	PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	22	n/a	n/a	n/a	n/a	n/a	n/a
AstraZeneca Curated by ChEMBL					Assay Description Inhibition of human BCL-2 overexpressed in mouse FDC-P1 cells assessed as cell viability after 24 hrs by Cell Titer Glo assay				Bioorg Med Chem Lett 24: 3026-33 (2014) Article DOI: 10.1016/j.bmcl.2014.05.036 BindingDB Entry DOI: 10.7270/Q27M09JW
					More data for this Ligand-Target Pair
Bcl-2-like protein 1 (Homo sapiens (Human))	BDBM50044927 (CHEMBL3309313) Show SMILES CN(C)CCOc1ccc(c(CN2CCN(CC2)c2ccc(cc2)C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN3CCOCC3)CSc3ccccc3)c(c2)S(=O)(=O)C(F)(F)F)c1)-c1ccc(Cl)cc1 |r| Show InChI InChI=1S/C49H56ClF3N6O7S3/c1-56(2)26-31-66-42-16-18-45(36-8-12-39(50)13-9-36)38(32-42)34-58-22-24-59(25-23-58)41-14-10-37(11-15-41)48(60)55-69(63,64)44-17-19-46(47(33-44)68(61,62)49(51,52)53)54-40(20-21-57-27-29-65-30-28-57)35-67-43-6-4-3-5-7-43/h3-19,32-33,40,54H,20-31,34-35H2,1-2H3,(H,55,60)/t40-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	10	n/a	n/a	n/a	n/a	n/a	n/a
AstraZeneca Curated by ChEMBL					Assay Description Inhibition of c-terminal 6xHis-tagged Bcl-xL (amino acids 1 to 209) (unknown origin) preincubated for 1 hr prior to substrate addition measured after...				Bioorg Med Chem Lett 24: 3026-33 (2014) Article DOI: 10.1016/j.bmcl.2014.05.036 BindingDB Entry DOI: 10.7270/Q27M09JW
					More data for this Ligand-Target Pair
Apoptosis regulator Bcl-2 (Homo sapiens (Human))	BDBM50044927 (CHEMBL3309313) Show SMILES CN(C)CCOc1ccc(c(CN2CCN(CC2)c2ccc(cc2)C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN3CCOCC3)CSc3ccccc3)c(c2)S(=O)(=O)C(F)(F)F)c1)-c1ccc(Cl)cc1 |r| Show InChI InChI=1S/C49H56ClF3N6O7S3/c1-56(2)26-31-66-42-16-18-45(36-8-12-39(50)13-9-36)38(32-42)34-58-22-24-59(25-23-58)41-14-10-37(11-15-41)48(60)55-69(63,64)44-17-19-46(47(33-44)68(61,62)49(51,52)53)54-40(20-21-57-27-29-65-30-28-57)35-67-43-6-4-3-5-7-43/h3-19,32-33,40,54H,20-31,34-35H2,1-2H3,(H,55,60)/t40-/m1/s1	PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	<10	n/a	n/a	n/a	n/a	n/a	n/a
AstraZeneca Curated by ChEMBL					Assay Description Inhibition of c-terminal 6xHis-tagged Bcl-2 (amino acids 1 to 204) (unknown origin) preincubated for 1 hr prior to substrate addition measured after ...				Bioorg Med Chem Lett 24: 3026-33 (2014) Article DOI: 10.1016/j.bmcl.2014.05.036 BindingDB Entry DOI: 10.7270/Q27M09JW
					More data for this Ligand-Target Pair
Bcl-2-like protein 1 (Homo sapiens (Human))	BDBM50044927 (CHEMBL3309313) Show SMILES CN(C)CCOc1ccc(c(CN2CCN(CC2)c2ccc(cc2)C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN3CCOCC3)CSc3ccccc3)c(c2)S(=O)(=O)C(F)(F)F)c1)-c1ccc(Cl)cc1 |r| Show InChI InChI=1S/C49H56ClF3N6O7S3/c1-56(2)26-31-66-42-16-18-45(36-8-12-39(50)13-9-36)38(32-42)34-58-22-24-59(25-23-58)41-14-10-37(11-15-41)48(60)55-69(63,64)44-17-19-46(47(33-44)68(61,62)49(51,52)53)54-40(20-21-57-27-29-65-30-28-57)35-67-43-6-4-3-5-7-43/h3-19,32-33,40,54H,20-31,34-35H2,1-2H3,(H,55,60)/t40-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	138	n/a	n/a	n/a	n/a	n/a	n/a
AstraZeneca Curated by ChEMBL					Assay Description Inhibition of human BCL-xL overexpressed in mouse FDC-P1 cells assessed as cell viability after 24 hrs by Cell Titer Glo assay				Bioorg Med Chem Lett 24: 3026-33 (2014) Article DOI: 10.1016/j.bmcl.2014.05.036 BindingDB Entry DOI: 10.7270/Q27M09JW
					More data for this Ligand-Target Pair